Shopping Cart 0
Cart Subtotal
USD 0

North America Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2480

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 3250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 4000

Details

North America artificial intelligence (AI) in drug discovery market is expected to grow by 29.5% annually in the forecast period and reach USD 894.1 million by 2026 despite the COVID-19 impact.

Highlighted with 27 tables and 50 figures, this 117-page report North America Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

o Market Structure

o Growth Drivers

o Restraints and Challenges

o Emerging Product Trends & Market Opportunities

o Porter's Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country.

Based on offering, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Software

o Service

Based on technology, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Deep Learning

o Supervised Learning

o Reinforcement Learning

o Unsupervised Learning

o Other Technologies

Based on drug type, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Large-molecule Drugs

o Small-molecular Drugs

Based on therapeutic area, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Oncology

o Neurodegenerative Diseases

o Cardiovascular Disease

o Metabolic Diseases

o Other Therapeutic Areas

Based on application, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Information & Data Analysis

o Drug Design

o Drug Evaluation

o Clinical Trials

o Other Applications

Based on end user, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Pharmaceutical & Biotechnology Companies

o Academic & Research Institutes

o Contract Research Organizations

Geographically, the following national/local markets are fully investigated:

o U.S.

o Canada

o Mexico

For each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America AI in drug discovery market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Table Of Content

Scope

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 14

1.2.6 Market Size/Share Estimation 15

1.2.7 Research Limitations 16

1.3 Executive Summary 17

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.2 Major Growth Drivers 22

2.3 Market Restraints and Challenges 25

2.4 Emerging Opportunities and Market Trends 28

2.5 Porter's Fiver Forces Analysis 32

3 Segmentation of North America Market by Offering 36

3.1 Market Overview by Offering 36

3.2 Software 38

3.3 Service 39

4 Segmentation of North America Market by Technology 40

4.1 Market Overview by Technology 40

4.2 Deep Learning 42

4.3 Supervised Learning 43

4.4 Reinforcement Learning 44

4.5 Unsupervised Learning 45

4.6 Other Technologies 46

5 Segmentation of North America Market by Drug Type 47

5.1 Market Overview by Drug Type 47

5.2 Large-molecule Drugs 49

5.3 Small-molecular Drugs 50

6 Segmentation of North America Market by Therapeutic Area 51

6.1 Market Overview by Therapeutic Area 51

6.2 Oncology 54

6.3 Neurodegenerative Diseases 55

6.4 Cardiovascular Disease 56

6.5 Metabolic Diseases 57

6.6 Other Therapeutic Areas 58

7 Segmentation of North America Market by Application 59

7.1 Market Overview by Application 59

7.2 Information & Data Analysis 61

7.3 Drug Design 62

7.4 Drug Evaluation 63

7.5 Clinical Trials 64

7.6 Other Applications 65

8 Segmentation of North America Market by End User 66

8.1 Market Overview by End User 66

8.2 Pharmaceutical & Biotechnology Companies 68

8.3 Academic & Research Institutes 69

8.4 Contract Research Organizations 70

9 North America Market 2019-2026 by Country 71

9.1 Overview of North America Market 71

9.2 U.S. 75

9.3 Canada 79

9.4 Mexico 81

10 Competitive Landscape 83

10.1 Overview of Key Vendors 83

10.2 New Product Launch, Partnership, Investment, and M&A 88

10.3 Company Profiles 89

Atomwise, Inc. 89

BenevolentAI 91

Berg LLC 92

Bioage 93

BIOAGE 94

Cloud Pharmaceuticals, Inc. 95

Cyclica 96

Deep Genomics 97

Envisagenics 98

Exscientia 99

Google 100

IBM Corporation 101

Insilico Medicine 102

Microsoft Corporation 103

Numedii, Inc. 104

Numerate 105

NVIDIA Corporation 106

Owkin, Inc. 107

Twoxar, Incorporated 108

Verge Genomics 109

Xtalpi, Inc. 110

11 Investing in North America Market: Risk Assessment and Management 111

11.1 Risk Evaluation of North America Market 111

11.2 Critical Success Factors (CSFs) 114

Related Reports and Products 117


List Of Figure

Figure 1. Research Method Flow Chart 11

Figure 2. Breakdown of Primary Research 13

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15

Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 17

Figure 5. North America AI in Drug Discovery Market, 2019-2026, USD mn 20

Figure 6. Primary Drivers and Impact Factors of North America AI in Drug Discovery Market 22

Figure 7. Primary Restraints and Impact Factors of North America AI in Drug Discovery Market 25

Figure 8. Investment Opportunity Analysis 29

Figure 9. Porter's Fiver Forces Analysis of North America AI in Drug Discovery Market 32

Figure 10. Breakdown of North America AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue 36

Figure 11. Contribution to North America 2020-2026 Cumulative Revenue by Offering, Value (USD mn) and Share (%) 37

Figure 12. North America AI in Drug Discovery Market: Software, 2015-2026, USD mn 38

Figure 13. North America AI in Drug Discovery Market: Service, 2015-2026, USD mn 39

Figure 14. Breakdown of North America AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue 40

Figure 15. Contribution to North America 2020-2026 Cumulative Revenue by Technology, Value (USD mn) and Share (%) 41

Figure 16. North America AI in Drug Discovery Market: Deep Learning, 2015-2026, USD mn 42

Figure 17. North America AI in Drug Discovery Market: Supervised Learning, 2015-2026, USD mn 43

Figure 18. North America AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, USD mn 44

Figure 19. North America AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, USD mn 45

Figure 20. North America AI in Drug Discovery Market: Other Technologies, 2015-2026, USD mn 46

Figure 21. Breakdown of North America AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue 47

Figure 22. Contribution to North America 2020-2026 Cumulative Revenue by Drug Type, Value (USD mn) and Share (%) 48

Figure 23. North America AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, USD mn 49

Figure 24. North America AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, USD mn 50

Figure 25. Breakdown of North America AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue 51

Figure 26. Contribution to North America 2020-2026 Cumulative Revenue by Therapeutic Area, Value (USD mn) and Share (%) 52

Figure 27. North America AI in Drug Discovery Market: Oncology, 2015-2026, USD mn 54

Figure 28. North America AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, USD mn 55

Figure 29. North America AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, USD mn 56

Figure 30. North America AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, USD mn 57

Figure 31. North America AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, USD mn 58

Figure 32. Breakdown of North America AI in Drug Discovery Market by Application, 2019-2026, % of Revenue 59

Figure 33. Contribution to North America 2020-2026 Cumulative Revenue by Application, Value (USD mn) and Share (%) 60

Figure 34. North America AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, USD mn 61

Figure 35. North America AI in Drug Discovery Market: Drug Design, 2015-2026, USD mn 62

Figure 36. North America AI in Drug Discovery Market: Drug Evaluation, 2015-2026, USD mn 63

Figure 37. North America AI in Drug Discovery Market: Clinical Trials, 2015-2026, USD mn 64

Figure 38. North America AI in Drug Discovery Market: Other Applications, 2015-2026, USD mn 65

Figure 39. Breakdown of North America AI in Drug Discovery Market by End User, 2019-2026, % of Revenue 66

Figure 40. Contribution to North America 2020-2026 Cumulative Revenue by End User, Value (USD mn) and Share (%) 67

Figure 41. North America AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, USD mn 68

Figure 42. North America AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, USD mn 69

Figure 43. North America AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, USD mn 70

Figure 44. Breakdown of North America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 72

Figure 45. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 73

Figure 46. U.S. AI in Drug Discovery Market, 2015-2026, USD mn 76

Figure 47. Canada AI in Drug Discovery Market, 2015-2026, USD mn 79

Figure 48. AI in Drug Discovery Market in Mexico, 2015-2026, USD mn 81

Figure 49. Growth Stage of North America AI in Drug Discovery Industry over the Forecast Period 83

Figure 50. Share of Developments of Key Vendors by Strategy Type, 2015-2019 85


List Of Table

Table 1. Snapshot of North America AI in Drug Discovery Market, 2019-2026 18

Table 2. Main Product Trends and Market Opportunities in North America AI in Drug Discovery Market 28

Table 3. North America AI in Drug Discovery Market by Offering, 2015-2026, USD mn 36

Table 4. North America AI in Drug Discovery Market by Technology, 2015-2026, USD mn 40

Table 5. North America AI in Drug Discovery Market by Drug Type, 2015-2026, USD mn 47

Table 6. North America AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 51

Table 7. Selected Drug Development Pipelines Aided by AI 53

Table 8. North America AI in Drug Discovery Market by Application, 2015-2026, USD mn 59

Table 9. North America AI in Drug Discovery Market by End User, 2015-2026, USD mn 66

Table 10. North America AI in Drug Discovery Market by Country, 2015-2026, USD mn 72

Table 11. U.S. AI in Drug Discovery Market by Technology, 2015-2026, USD mn 77

Table 12. U.S. AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 77

Table 13. U.S. AI in Drug Discovery Market by End User, 2015-2026, USD mn 77

Table 14. Canada AI in Drug Discovery Market by Technology, 2015-2026, USD mn 80

Table 15. Canada AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 80

Table 16. Canada AI in Drug Discovery Market by End User, 2015-2026, USD mn 80

Table 17. Mexico AI in Drug Discovery Market by Technology, 2015-2026, USD mn 82

Table 18. Mexico AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 82

Table 19. Mexico AI in Drug Discovery Market by End User, 2015-2026, USD mn 82

Table 20. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies 86

Table 21. Atomwise, Inc.: Company Snapshot 89

Table 22. Atomwise, Inc.: Business Segmentation 89

Table 23. Atomwise, Inc.: Product Portfolio 90

Table 24. Atomwise, Inc.: Revenue, 2016-2018, USD mn 90

Table 25. Atomwise, Inc.: Recent Developments 90

Table 26. Risk Evaluation for Investing in North America Market, 2019-2026 112

Table 27. Critical Success Factors and Key Takeaways 115

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.

Company Profile

Company Profile Title

North America artificial intelligence (AI) in drug discovery market is expected to grow by 29.5% annually in the forecast period and reach USD 894.1 million by 2026 despite the COVID-19 impact.

Highlighted with 27 tables and 50 figures, this 117-page report North America Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

o Market Structure

o Growth Drivers

o Restraints and Challenges

o Emerging Product Trends & Market Opportunities

o Porter's Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country.

Based on offering, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Software

o Service

Based on technology, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Deep Learning

o Supervised Learning

o Reinforcement Learning

o Unsupervised Learning

o Other Technologies

Based on drug type, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Large-molecule Drugs

o Small-molecular Drugs

Based on therapeutic area, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Oncology

o Neurodegenerative Diseases

o Cardiovascular Disease

o Metabolic Diseases

o Other Therapeutic Areas

Based on application, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Information & Data Analysis

o Drug Design

o Drug Evaluation

o Clinical Trials

o Other Applications

Based on end user, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

o Pharmaceutical & Biotechnology Companies

o Academic & Research Institutes

o Contract Research Organizations

Geographically, the following national/local markets are fully investigated:

o U.S.

o Canada

o Mexico

For each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America AI in drug discovery market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Scope

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 14

1.2.6 Market Size/Share Estimation 15

1.2.7 Research Limitations 16

1.3 Executive Summary 17

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.2 Major Growth Drivers 22

2.3 Market Restraints and Challenges 25

2.4 Emerging Opportunities and Market Trends 28

2.5 Porter's Fiver Forces Analysis 32

3 Segmentation of North America Market by Offering 36

3.1 Market Overview by Offering 36

3.2 Software 38

3.3 Service 39

4 Segmentation of North America Market by Technology 40

4.1 Market Overview by Technology 40

4.2 Deep Learning 42

4.3 Supervised Learning 43

4.4 Reinforcement Learning 44

4.5 Unsupervised Learning 45

4.6 Other Technologies 46

5 Segmentation of North America Market by Drug Type 47

5.1 Market Overview by Drug Type 47

5.2 Large-molecule Drugs 49

5.3 Small-molecular Drugs 50

6 Segmentation of North America Market by Therapeutic Area 51

6.1 Market Overview by Therapeutic Area 51

6.2 Oncology 54

6.3 Neurodegenerative Diseases 55

6.4 Cardiovascular Disease 56

6.5 Metabolic Diseases 57

6.6 Other Therapeutic Areas 58

7 Segmentation of North America Market by Application 59

7.1 Market Overview by Application 59

7.2 Information & Data Analysis 61

7.3 Drug Design 62

7.4 Drug Evaluation 63

7.5 Clinical Trials 64

7.6 Other Applications 65

8 Segmentation of North America Market by End User 66

8.1 Market Overview by End User 66

8.2 Pharmaceutical & Biotechnology Companies 68

8.3 Academic & Research Institutes 69

8.4 Contract Research Organizations 70

9 North America Market 2019-2026 by Country 71

9.1 Overview of North America Market 71

9.2 U.S. 75

9.3 Canada 79

9.4 Mexico 81

10 Competitive Landscape 83

10.1 Overview of Key Vendors 83

10.2 New Product Launch, Partnership, Investment, and M&A 88

10.3 Company Profiles 89

Atomwise, Inc. 89

BenevolentAI 91

Berg LLC 92

Bioage 93

BIOAGE 94

Cloud Pharmaceuticals, Inc. 95

Cyclica 96

Deep Genomics 97

Envisagenics 98

Exscientia 99

Google 100

IBM Corporation 101

Insilico Medicine 102

Microsoft Corporation 103

Numedii, Inc. 104

Numerate 105

NVIDIA Corporation 106

Owkin, Inc. 107

Twoxar, Incorporated 108

Verge Genomics 109

Xtalpi, Inc. 110

11 Investing in North America Market: Risk Assessment and Management 111

11.1 Risk Evaluation of North America Market 111

11.2 Critical Success Factors (CSFs) 114

Related Reports and Products 117


List Of Figure

Figure 1. Research Method Flow Chart 11

Figure 2. Breakdown of Primary Research 13

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15

Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 17

Figure 5. North America AI in Drug Discovery Market, 2019-2026, USD mn 20

Figure 6. Primary Drivers and Impact Factors of North America AI in Drug Discovery Market 22

Figure 7. Primary Restraints and Impact Factors of North America AI in Drug Discovery Market 25

Figure 8. Investment Opportunity Analysis 29

Figure 9. Porter's Fiver Forces Analysis of North America AI in Drug Discovery Market 32

Figure 10. Breakdown of North America AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue 36

Figure 11. Contribution to North America 2020-2026 Cumulative Revenue by Offering, Value (USD mn) and Share (%) 37

Figure 12. North America AI in Drug Discovery Market: Software, 2015-2026, USD mn 38

Figure 13. North America AI in Drug Discovery Market: Service, 2015-2026, USD mn 39

Figure 14. Breakdown of North America AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue 40

Figure 15. Contribution to North America 2020-2026 Cumulative Revenue by Technology, Value (USD mn) and Share (%) 41

Figure 16. North America AI in Drug Discovery Market: Deep Learning, 2015-2026, USD mn 42

Figure 17. North America AI in Drug Discovery Market: Supervised Learning, 2015-2026, USD mn 43

Figure 18. North America AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, USD mn 44

Figure 19. North America AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, USD mn 45

Figure 20. North America AI in Drug Discovery Market: Other Technologies, 2015-2026, USD mn 46

Figure 21. Breakdown of North America AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue 47

Figure 22. Contribution to North America 2020-2026 Cumulative Revenue by Drug Type, Value (USD mn) and Share (%) 48

Figure 23. North America AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, USD mn 49

Figure 24. North America AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, USD mn 50

Figure 25. Breakdown of North America AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue 51

Figure 26. Contribution to North America 2020-2026 Cumulative Revenue by Therapeutic Area, Value (USD mn) and Share (%) 52

Figure 27. North America AI in Drug Discovery Market: Oncology, 2015-2026, USD mn 54

Figure 28. North America AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, USD mn 55

Figure 29. North America AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, USD mn 56

Figure 30. North America AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, USD mn 57

Figure 31. North America AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, USD mn 58

Figure 32. Breakdown of North America AI in Drug Discovery Market by Application, 2019-2026, % of Revenue 59

Figure 33. Contribution to North America 2020-2026 Cumulative Revenue by Application, Value (USD mn) and Share (%) 60

Figure 34. North America AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, USD mn 61

Figure 35. North America AI in Drug Discovery Market: Drug Design, 2015-2026, USD mn 62

Figure 36. North America AI in Drug Discovery Market: Drug Evaluation, 2015-2026, USD mn 63

Figure 37. North America AI in Drug Discovery Market: Clinical Trials, 2015-2026, USD mn 64

Figure 38. North America AI in Drug Discovery Market: Other Applications, 2015-2026, USD mn 65

Figure 39. Breakdown of North America AI in Drug Discovery Market by End User, 2019-2026, % of Revenue 66

Figure 40. Contribution to North America 2020-2026 Cumulative Revenue by End User, Value (USD mn) and Share (%) 67

Figure 41. North America AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, USD mn 68

Figure 42. North America AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, USD mn 69

Figure 43. North America AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, USD mn 70

Figure 44. Breakdown of North America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 72

Figure 45. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value (USD mn) and Share (%) 73

Figure 46. U.S. AI in Drug Discovery Market, 2015-2026, USD mn 76

Figure 47. Canada AI in Drug Discovery Market, 2015-2026, USD mn 79

Figure 48. AI in Drug Discovery Market in Mexico, 2015-2026, USD mn 81

Figure 49. Growth Stage of North America AI in Drug Discovery Industry over the Forecast Period 83

Figure 50. Share of Developments of Key Vendors by Strategy Type, 2015-2019 85


List Of Table

Table 1. Snapshot of North America AI in Drug Discovery Market, 2019-2026 18

Table 2. Main Product Trends and Market Opportunities in North America AI in Drug Discovery Market 28

Table 3. North America AI in Drug Discovery Market by Offering, 2015-2026, USD mn 36

Table 4. North America AI in Drug Discovery Market by Technology, 2015-2026, USD mn 40

Table 5. North America AI in Drug Discovery Market by Drug Type, 2015-2026, USD mn 47

Table 6. North America AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 51

Table 7. Selected Drug Development Pipelines Aided by AI 53

Table 8. North America AI in Drug Discovery Market by Application, 2015-2026, USD mn 59

Table 9. North America AI in Drug Discovery Market by End User, 2015-2026, USD mn 66

Table 10. North America AI in Drug Discovery Market by Country, 2015-2026, USD mn 72

Table 11. U.S. AI in Drug Discovery Market by Technology, 2015-2026, USD mn 77

Table 12. U.S. AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 77

Table 13. U.S. AI in Drug Discovery Market by End User, 2015-2026, USD mn 77

Table 14. Canada AI in Drug Discovery Market by Technology, 2015-2026, USD mn 80

Table 15. Canada AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 80

Table 16. Canada AI in Drug Discovery Market by End User, 2015-2026, USD mn 80

Table 17. Mexico AI in Drug Discovery Market by Technology, 2015-2026, USD mn 82

Table 18. Mexico AI in Drug Discovery Market by Therapeutic Area, 2015-2026, USD mn 82

Table 19. Mexico AI in Drug Discovery Market by End User, 2015-2026, USD mn 82

Table 20. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies 86

Table 21. Atomwise, Inc.: Company Snapshot 89

Table 22. Atomwise, Inc.: Business Segmentation 89

Table 23. Atomwise, Inc.: Product Portfolio 90

Table 24. Atomwise, Inc.: Revenue, 2016-2018, USD mn 90

Table 25. Atomwise, Inc.: Recent Developments 90

Table 26. Risk Evaluation for Investing in North America Market, 2019-2026 112

Table 27. Critical Success Factors and Key Takeaways 115

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.